Xeljanz

Xeljanz (tofacitinib) is an oral medication used for managing certain inflammatory conditions. It belongs to the JAK inhibitor class and is prescribed for adults with moderate to severe rheumatoid arthritis or psoriatic arthritis. Always consult a healthcare provider before use.

Xeljanz is primarily used to treat moderate to severe rheumatoid arthritis in adults who have not responded well to methotrexate. It is also prescribed for active psoriatic arthritis and may be considered for ulcerative colitis in adults. Patients often ask, 'What is tofacitinib used for?' as it targets specific immune pathways to reduce inflammation and joint damage.

Xeljanz works by interfering with certain enzymes in the body that contribute to inflammation. This helps reduce symptoms like joint pain, swelling, and stiffness. Some users may notice improved mobility and daily functioning over time. Effects can vary, and consistent use is often required for best results.

Xeljanz should be handled with care, especially for individuals with a history of infections or liver problems. Regular blood tests may be recommended to monitor for potential side effects. It is important to store the medication in a cool, dry place away from direct sunlight. Keep out of reach of children.

Xeljanz may interact with other medications, including certain antifungals, antibiotics, and immunosuppressants. Combining it with strong CYP3A4 inhibitors can increase the risk of side effects. Alcohol and tobacco may also affect how the medication works. Always inform your healthcare provider about all medications you are taking.